StockData
Embecta Corp. logo

Embecta Corp. (EMBC) stock

EMBCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 15/3079% below fair value
$6.43−0.10 (-1.53%)

Close on Nov 12, 2026Market cap $364.32MP/E 4.4Yield 9.33%

Embecta operating margin

Operating margin is operating income as a percentage of revenue.

Embecta's operating margin for the twelve months ending Jun 30, 2026 was 21.9%. For fiscal 2025 it was 22.4%, against 14.9% the year before. The highest annual figure on record is 44.8% in fiscal 2020.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Sep 30, 202522.4%+7.6
FY2024Sep 30, 202414.9%−4.9
FY2023Sep 30, 202319.8%−7.6
FY2022Sep 30, 202227.4%−14.8
FY2021Sep 30, 202142.2%−2.6
FY2020Sep 30, 202044.8%–

Quarterly operating margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q3 FY2026CQ2 2026Jun 30, 202617.9%−13.9
Q2 FY2026CQ1 2026Mar 31, 202615.8%−8.5
Q1 FY2026CQ4 2025Dec 31, 202531.9%+20.9
Q4 FY2025CQ3 2025Sep 30, 202521.4%+12.2
Q3 FY2025CQ2 2025Jun 30, 202531.8%+11.3
Q2 FY2025CQ1 2025Mar 31, 202524.3%+10.6
Q1 FY2025CQ4 2024Dec 31, 202411.0%−5.4
Q4 FY2024CQ3 2024Sep 30, 20249.2%+0.0
Q3 FY2024CQ2 2024Jun 30, 202420.5%+2.6
Q2 FY2024CQ1 2024Mar 31, 202413.6%−6.4
Q1 FY2024CQ4 2023Dec 31, 202316.4%−15.8
Q4 FY2023CQ3 2023Sep 30, 20239.2%+10.2
Q3 FY2023CQ2 2023Jun 30, 202317.9%−15.4
Q2 FY2023CQ1 2023Mar 31, 202320.1%−16.0
Q1 FY2023CQ4 2022Dec 31, 202232.2%−8.1
Q4 FY2022CQ3 2022Sep 30, 2022-1.1%−40.1
Q3 FY2022CQ2 2022Jun 30, 202233.4%−8.8
Q2 FY2022CQ1 2022Mar 31, 202236.0%−8.4
Q1 FY2022CQ4 2021Dec 31, 202140.3%−3.2
Q4 FY2021CQ3 2021Sep 30, 202139.0%–
Q3 FY2021CQ2 2021Jun 30, 202142.1%–
Q2 FY2021CQ1 2021Mar 31, 202144.5%–
Q1 FY2021CQ4 2020Dec 31, 202043.5%–

More Embecta figures

See a number that looks wrong?